Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
474K
-
Shares change
-
-9.94K
-
Total reported value, excl. options
-
$2.46M
-
Value change
-
-$16.1K
-
Number of buys
-
6
-
Number of sells
-
-7
-
Price
-
$5.20
Significant Holders of Lipocine Inc. - COM NEW (LPCN) as of Q1 2024
21 filings reported holding LPCN - Lipocine Inc. - COM NEW as of Q1 2024.
Lipocine Inc. - COM NEW (LPCN) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 474K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (221K shares), BlackRock Inc. (74.5K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (59.7K shares), GEODE CAPITAL MANAGEMENT, LLC (48.9K shares), TWO SIGMA ADVISERS, LP (25.7K shares), RENAISSANCE TECHNOLOGIES LLC (21.1K shares), STATE STREET CORP (18.6K shares), Tower Research Capital LLC (TRC) (2.01K shares), MORGAN STANLEY (722 shares), and CALDWELL SUTTER CAPITAL, INC. (471 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.